{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T02:48:54Z","timestamp":1788576534517,"version":"build-2803163510"},"reference-count":143,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2024,6,8]],"date-time":"2024-06-08T00:00:00Z","timestamp":1717804800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Pancreatic cancer is a prevalent lethal gastrointestinal cancer that generally does not show any symptoms until it reaches advanced stages, resulting in a high mortality rate. People at high risk, such as those with a family history or chronic pancreatitis, do not have a universally accepted screening protocol. Chemotherapy and radiotherapy demonstrate limited effectiveness in the management of pancreatic cancer, emphasizing the urgent need for innovative therapeutic strategies. Recent studies indicated that the complex interaction among pancreatic cancer cells within the dynamic microenvironment, comprising the extracellular matrix, cancer-associated cells, and diverse immune cells, intricately regulates the biological characteristics of the disease. Additionally, mounting evidence suggests that EVs play a crucial role as mediators in intercellular communication by the transportation of different biomolecules, such as miRNA, proteins, DNA, mRNA, and lipids, between heterogeneous cell subpopulations. This communication mediated by EVs significantly impacts multiple aspects of pancreatic cancer pathogenesis, including proliferation, angiogenesis, metastasis, and resistance to therapy. In this review, we delve into the pivotal role of EV-associated miRNAs in the progression, metastasis, and development of drug resistance in pancreatic cancer as well as their therapeutic potential as biomarkers and drug-delivery mechanisms for the management of pancreatic cancer.<\/jats:p>","DOI":"10.3390\/cancers16122179","type":"journal-article","created":{"date-parts":[[2024,6,10]],"date-time":"2024-06-10T08:59:06Z","timestamp":1718009946000},"page":"2179","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Extracellular Vesicular miRNA in Pancreatic Cancer: From Lab to Therapy"],"prefix":"10.3390","volume":"16","author":[{"given":"Prashant Kumar","family":"Tiwari","sequence":"first","affiliation":[{"name":"Biological and Bio-Computational Lab, Department of Life Science, School of Basic Sciences and Research, Sharda University, Greater Noida 201310, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Poojhaa","family":"Shanmugam","sequence":"additional","affiliation":[{"name":"Amity Institute of Biotechnology, Amity University, Mumbai 410206, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vamika","family":"Karn","sequence":"additional","affiliation":[{"name":"Amity Institute of Biotechnology, Amity University, Mumbai 410206, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8140-2033","authenticated-orcid":false,"given":"Saurabh","family":"Gupta","sequence":"additional","affiliation":[{"name":"Department of Biotechnology, GLA University, Mathura 281406, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1173-8962","authenticated-orcid":false,"given":"Richa","family":"Mishra","sequence":"additional","affiliation":[{"name":"Department of Computer Engineering, Parul University, Ta. Waghodia, Vadodara 391760, Gujarat, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarvesh","family":"Rustagi","sequence":"additional","affiliation":[{"name":"School of Applied and Life science, Uttaranchal University, Dehradun 248007, Uttarakhand, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mandeep","family":"Chouhan","sequence":"additional","affiliation":[{"name":"Biological and Bio-Computational Lab, Department of Life Science, School of Basic Sciences and Research, Sharda University, Greater Noida 201310, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0654-2009","authenticated-orcid":false,"given":"Devvret","family":"Verma","sequence":"additional","affiliation":[{"name":"Department of Biotechnology, Graphic Era (Deemed to be University), Dehradun 248002, Uttarakhand, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9486-4069","authenticated-orcid":false,"given":"Niraj Kumar","family":"Jha","sequence":"additional","affiliation":[{"name":"Centre for Global Health Research, Saveetha Medical College, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai 602105, Tamil Nadu, India"},{"name":"School of Bioengineering & Biosciences, Lovely Professional University, Phagwara 144411, Punjab, India"},{"name":"Department of Biotechnology, Sharda School of Engineering and Technology, Sharda University, Greater Noida 201310, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6296-0291","authenticated-orcid":false,"given":"Sanjay","family":"Kumar","sequence":"additional","affiliation":[{"name":"Biological and Bio-Computational Lab, Department of Life Science, School of Basic Sciences and Research, Sharda University, Greater Noida 201310, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,6,8]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"5851","DOI":"10.3748\/wjg.v27.i35.5851","article-title":"Pancreatic Cancer in 2021: What You Need to Know to Win","volume":"27","author":"Tonini","year":"2021","journal-title":"World J. Gastroenterol."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Kumar, L., Kumar, S., Sandeep, K., and Patel, S.K.S. (2023). Therapeutic Approaches in Pancreatic Cancer: Recent Updates. Biomedicines, 11.","DOI":"10.3390\/biomedicines11061611"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0140-6736(16)00141-0","article-title":"Pancreatic Cancer","volume":"388","author":"Kamisawa","year":"2016","journal-title":"Lancet"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"16022","DOI":"10.1038\/nrdp.2016.22","article-title":"Pancreatic Cancer","volume":"2","author":"Kleeff","year":"2016","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Papadakos, S.P., Dedes, N., Gkolemi, N., Machairas, N., and Theocharis, S. (2023). The EPH\/Ephrin System in Pancreatic Ductal Adenocarcinoma (PDAC): From Pathogenesis to Treatment. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24033015"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.3892\/or.2017.5919","article-title":"Upregulated Exosomic MiR-23b-3p Plays Regulatory Roles in the Progression of Pancreatic Cancer","volume":"38","author":"Chen","year":"2017","journal-title":"Oncol. Rep."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"e99263","DOI":"10.1172\/jci.insight.99263","article-title":"Generation and Testing of Clinical-Grade Exosomes for Pancreatic Cancer","volume":"3","author":"Mendt","year":"2018","journal-title":"JCI Insight"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Mok, E.T.Y., Chitty, J.L., and Cox, T.R. (2024). MiRNAs in Pancreatic Cancer Progression and Metastasis. Clin. Exp. Metastasis.","DOI":"10.1007\/s10585-023-10256-0"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"853480","DOI":"10.3389\/fimmu.2022.853480","article-title":"The Role of NcRNAs to Regulate Immune Checkpoints in Cancer","volume":"13","author":"Jiang","year":"2022","journal-title":"Front. Immunol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"8884642","DOI":"10.1155\/2021\/8884642","article-title":"Diagnostic and Therapeutic Potential of Exosomal MicroRNAs for Neurodegenerative Diseases","volume":"2021","author":"He","year":"2021","journal-title":"Neural Plast."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Woith, E., Fuhrmann, G., and Melzig, M.F. (2019). Extracellular Vesicles\u2014Connecting Kingdoms. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20225695"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/s41565-021-00931-2","article-title":"Extracellular Vesicles as a Next-Generation Drug Delivery Platform","volume":"16","author":"Herrmann","year":"2021","journal-title":"Nat. Nanotechnol."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Karn, V., Ahmed, S., Tsai, L.-W., Dubey, R., Ojha, S., Singh, H.N., Kumar, M., Gupta, P.K., Sadhu, S., and Jha, N.K. (2021). Extracellular Vesicle-Based Therapy for COVID-19: Promises, Challenges and Future Prospects. Biomedicines, 9.","DOI":"10.3390\/biomedicines9101373"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1186\/s13023-020-01607-1","article-title":"Specific Populations of Urinary Extracellular Vesicles and Proteins Differentiate Type 1 Primary Hyperoxaluria Patients without and with Nephrocalcinosis or Kidney Stones","volume":"15","author":"Jayachandran","year":"2020","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Zhang, J., Kumar, S., Jayachandran, M., Herrera Hernandez, L.P., Wang, S., Wilson, E.M., and Lieske, J.C. (2021). Excretion of Urine Extracellular Vesicles Bearing Markers of Activated Immune Cells and Calcium\/Phosphorus Physiology Differ between Calcium Kidney Stone Formers and Non-Stone Formers. BMC Nephrol., 22.","DOI":"10.1186\/s12882-021-02417-8"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1210\/er.2017-00229","article-title":"Extracellular Vesicles in Human Reproduction in Health and Disease","volume":"39","author":"Simon","year":"2018","journal-title":"Endocr. Rev."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Lin, Z., Jayachandran, M., Haskic, Z., Kumar, S., and Lieske, J.C. (2022). Differences of Uric Acid Transporters Carrying Extracellular Vesicles in the Urine from Uric Acid and Calcium Stone Formers and Non-Stone Formers. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms231710010"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Jin, Y., Ma, L., Zhang, W., Yang, W., Feng, Q., and Wang, H. (2022). Extracellular Signals Regulate the Biogenesis of Extracellular Vesicles. Biol. Res., 55.","DOI":"10.1186\/s40659-022-00405-2"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/nrm.2016.121","article-title":"Reverse-Topology Membrane Scission by the ESCRT Proteins","volume":"18","author":"Lee","year":"2017","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s41580-019-0177-4","article-title":"The Many Functions of ESCRTs","volume":"21","author":"Vietri","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1146\/annurev-cellbio-101512-122326","article-title":"Biogenesis, Secretion, and Intercellular Interactions of Exosomes and Other Extracellular Vesicles","volume":"30","author":"Colombo","year":"2014","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Lambert, M., Benmoussa, A., and Provost, P. (2019). Small Non-Coding RNAs Derived from Eukaryotic Ribosomal RNA. Non-Coding RNA, 5.","DOI":"10.3390\/ncrna5010016"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"e1701","DOI":"10.1002\/wrna.1701","article-title":"Regulation and Different Functions of the Animal MicroRNA-Induced Silencing Complex","volume":"13","author":"Simard","year":"2022","journal-title":"WIREs RNA"},{"key":"ref_24","first-page":"12313","article-title":"Expression and Functional Perspectives of MiR-184 in Pancreatic Ductal Adenocarcinoma","volume":"8","author":"Li","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1038\/ajg.2014.331","article-title":"A Pilot Study to Develop a Diagnostic Test for Pancreatic Ductal Adenocarcinoma Based on Differential Expression of Select MiRNA in Plasma and Bile","volume":"109","author":"Cote","year":"2014","journal-title":"Off. J. Am. Coll. Gastroenterol. ACG"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"e10250","DOI":"10.7554\/eLife.10250","article-title":"Tumor Microenvironment Derived Exosomes Pleiotropically Modulate Cancer Cell Metabolism","volume":"5","author":"Zhao","year":"2016","journal-title":"eLife"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"9329","DOI":"10.2147\/OTT.S229494","article-title":"Serum Derived Exosomes from Pancreatic Cancer Patients Promoted Metastasis: An ITRAQ-Based Proteomic Analysis","volume":"12","author":"Tang","year":"2019","journal-title":"OncoTargets Ther."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1146\/annurev-biochem-013118-111902","article-title":"Exosomes","volume":"88","author":"Pegtel","year":"2019","journal-title":"Annu. Rev. Biochem."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"e40226","DOI":"10.7554\/eLife.40226","article-title":"Human Pancreatic Cancer Cell Exosomes, but Not Human Normal Cell Exosomes, Act as an Initiator in Cell Transformation","volume":"8","author":"Stefanius","year":"2019","journal-title":"eLife"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"7728","DOI":"10.1002\/cam4.2633","article-title":"Exosomal MiRNA-1231 Derived from Bone Marrow Mesenchymal Stem Cells Inhibits the Activity of Pancreatic Cancer","volume":"8","author":"Shang","year":"2019","journal-title":"Cancer Med."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s13046-018-0739-x","article-title":"MiR-10a-5p Targets TFAP2C to Promote Gemcitabine Resistance in Pancreatic Ductal Adenocarcinoma","volume":"37","author":"Xiong","year":"2018","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"37082","DOI":"10.1074\/jbc.M113.517953","article-title":"The Autoregulatory Feedback Loop of MicroRNA-21\/Programmed Cell Death Protein 4\/Activation Protein-1 (MiR-21\/PDCD4\/AP-1) as a Driving Force for Hepatic Fibrosis Development","volume":"288","author":"Zhang","year":"2013","journal-title":"J. Biol. Chem."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"117857","DOI":"10.1016\/j.lfs.2020.117857","article-title":"Role of Exosomal MicroRNA-125b-5p in Conferring the Metastatic Phenotype among Pancreatic Cancer Cells with Different Potential of Metastasis","volume":"255","author":"Wu","year":"2020","journal-title":"Life Sci."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"154538","DOI":"10.1016\/j.prp.2023.154538","article-title":"Molecular Mechanisms of MicroRNA-301a during Tumor Progression and Metastasis","volume":"247","author":"Fanoodi","year":"2023","journal-title":"Pathol. Res. Pract."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1159\/000495281","article-title":"Tumor-Secreted Exosomal MiR-222 Promotes Tumor Progression via Regulating P27 Expression and Re-Localization in Pancreatic Cancer","volume":"51","author":"Li","year":"2018","journal-title":"Cell Physiol. Biochem."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1186\/s13046-019-1313-x","article-title":"Macrophage-Derived Exosomal MicroRNA-501-3p Promotes Progression of Pancreatic Ductal Adenocarcinoma through the TGFBR3-Mediated TGF-\u03b2 Signaling Pathway","volume":"38","author":"Yin","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s13046-015-0236-4","article-title":"CMTM4 Is Frequently Downregulated and Functions as a Tumour Suppressor in Clear Cell Renal Cell Carcinoma","volume":"34","author":"Li","year":"2015","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1093\/abbs\/gmz084","article-title":"CMTM4 Inhibits Cell Proliferation and Migration via AKT, ERK1\/2, and STAT3 Pathway in Colorectal Cancer","volume":"51","author":"Xue","year":"2019","journal-title":"Acta Biochim. Biophys. Sin."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"5028","DOI":"10.1111\/jcmm.15125","article-title":"Down-Regulated LncRNA SBF2-AS1 in M2 Macrophage-Derived Exosomes Elevates MiR-122-5p to Restrict XIAP, Thereby Limiting Pancreatic Cancer Development","volume":"24","author":"Yin","year":"2020","journal-title":"J. Cell. Mol. Med."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/j.gendis.2022.10.019","article-title":"The Role of TGF-\u03b2 in the Tumor Microenvironment of Pancreatic Cancer","volume":"10","author":"Luo","year":"2023","journal-title":"Genes Dis."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"4586","DOI":"10.1158\/0008-5472.CAN-17-3841","article-title":"Hypoxic Tumor-Derived Exosomal MiR-301a Mediates M2 Macrophage Polarization via PTEN\/PI3K\u03b3 to Promote Pancreatic Cancer Metastasis","volume":"78","author":"Wang","year":"2018","journal-title":"Cancer Res."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"23323","DOI":"10.18632\/oncotarget.4492","article-title":"MicroRNA in Pancreatic Adenocarcinoma: Predictive\/Prognostic Biomarkers or Therapeutic Targets?","volume":"6","author":"Brunetti","year":"2015","journal-title":"Oncotarget"},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Ye, J., and Liu, X. (2022). Macrophage-Derived Small Extracellular Vesicles in Multiple Diseases: Biogenesis, Function, and Therapeutic Applications. Front. Cell Dev. Biol., 10.","DOI":"10.3389\/fcell.2022.913110"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.canlet.2020.06.009","article-title":"Pancreatic Stellate Cells Derived Exosomal MiR-5703 Promotes Pancreatic Cancer by Downregulating CMTM4 and Activating PI3K\/Akt Pathway","volume":"490","author":"Li","year":"2020","journal-title":"Cancer Lett."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.3892\/ol.2020.11691","article-title":"Circulating Exosomal MicroRNAs as Novel Potential Detection Biomarkers in Pancreatic Cancer","volume":"20","author":"Wu","year":"2020","journal-title":"Oncol. Lett."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.2147\/OTT.S296816","article-title":"Serum Exosomal MiRNA-1226 as Potential Biomarker of Pancreatic Ductal Adenocarcinoma","volume":"14","author":"Wang","year":"2021","journal-title":"OncoTargets Ther."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3892\/ijo.2021.5200","article-title":"Emerging Roles and Mechanisms of MicroRNA-222-3p in Human Cancer (Review)","volume":"58","author":"Wang","year":"2021","journal-title":"Int. J. Oncol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1186\/s12935-021-02059-8","article-title":"The Significance of Exosomal RNAs in the Development, Diagnosis, and Treatment of Pancreatic Cancer","volume":"21","author":"Zhao","year":"2021","journal-title":"Cancer Cell Int."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1111\/jcmm.14766","article-title":"Pancreatic Cancer Cell\u2013Derived Exosomal MicroRNA-27a Promotes Angiogenesis of Human Microvascular Endothelial Cells in Pancreatic Cancer via BTG2","volume":"24","author":"Shang","year":"2020","journal-title":"J. Cell. Mol. Med."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.semcancer.2018.03.001","article-title":"RAS-Mediated Oncogenic Signaling Pathways in Human Malignancies","volume":"54","author":"Khan","year":"2019","journal-title":"Semin. Cancer Biol."},{"key":"ref_51","first-page":"1025","article-title":"Upregulation of Exosomal MicroRNA-21 in Pancreatic Stellate Cells Promotes Pancreatic Cancer Cell Migration and Enhances Ras\/ERK Pathway Activity","volume":"56","author":"Ma","year":"2020","journal-title":"Int. J. Oncol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s13073-018-0535-4","article-title":"The Emerging Roles of Exosomes in the Modulation of Immune Responses in Cancer","volume":"10","author":"Kurywchak","year":"2018","journal-title":"Genome Med."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.semcancer.2014.05.003","article-title":"Harnessing the Exosome-Induced Immune Response for Cancer Immunotherapy","volume":"28","author":"Gehrmann","year":"2014","journal-title":"Semin. Cancer Biol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1016\/j.ymthe.2020.12.033","article-title":"Leukemic Extracellular Vesicles Induce Chimeric Antigen Receptor T Cell Dysfunction in Chronic Lymphocytic Leukemia","volume":"29","author":"Cox","year":"2021","journal-title":"Mol. Ther."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.3389\/fonc.2019.01148","article-title":"Immune System Evasion as Hallmark of Melanoma Progression: The Role of Dendritic Cells","volume":"9","author":"Tucci","year":"2019","journal-title":"Front. Oncol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.cellimm.2014.09.004","article-title":"Pancreatic Cancer Derived Exosomes Regulate the Expression of TLR4 in Dendritic Cells via MiR-203","volume":"292","author":"Zhou","year":"2014","journal-title":"Cell Immunol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"29877","DOI":"10.18632\/oncotarget.4924","article-title":"Pancreatic Cancer-Derived Exosomes Transfer MiRNAs to Dendritic Cells and Inhibit RFXAP Expression via MiR-212-3p","volume":"6","author":"Ding","year":"2015","journal-title":"Oncotarget"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1053\/j.gastro.2018.06.054","article-title":"Sweet Predictions Speak Volumes for Early Detection of Pancreatic Cancer","volume":"155","author":"Soreide","year":"2018","journal-title":"Gastroenterology"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.3748\/wjg.v24.i19.2047","article-title":"Challenges in Diagnosis of Pancreatic Cancer","volume":"24","author":"Zhang","year":"2018","journal-title":"World J. Gastroenterol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1007\/s00018-019-03035-2","article-title":"Exosomes: From Carcinogenesis and Metastasis to Diagnosis and Treatment of Gastric Cancer","volume":"76","author":"Kahroba","year":"2019","journal-title":"Cell Mol. Life Sci."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1801268","DOI":"10.1002\/adhm.201801268","article-title":"Exploiting Exosomes in Cancer Liquid Biopsies and Drug Delivery","volume":"8","author":"Fitts","year":"2019","journal-title":"Adv. Healthc. Mater."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1016\/j.bcp.2012.02.004","article-title":"MicroRNAs in Cancer Management and Their Modulation by Dietary Agents","volume":"83","author":"Karius","year":"2012","journal-title":"Biochem. Pharmacol."},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Rawat, M., Kadian, K., Gupta, Y., Kumar, A., Chain, P.S.G., Kovbasnjuk, O., Kumar, S., and Parasher, G. (2019). MicroRNA in Pancreatic Cancer: From Biology to Therapeutic Potential. Genes, 10.","DOI":"10.3390\/genes10100752"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/jhbp.524","article-title":"Usefulness of Exosome-Encapsulated MicroRNA-451a as a Minimally Invasive Biomarker for Prediction of Recurrence and Prognosis in Pancreatic Ductal Adenocarcinoma","volume":"25","author":"Takahasi","year":"2018","journal-title":"J. Hepato-Biliary-Pancreat. Sci."},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Guo, S., Fesler, A., Wang, H., and Ju, J. (2018). MicroRNA Based Prognostic Biomarkers in Pancreatic Cancer. Biomark. Res., 6.","DOI":"10.1186\/s40364-018-0131-1"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1007\/s00268-012-1705-y","article-title":"Prognostic MicroRNAs in Cancer Tissue from Patients Operated for Pancreatic Cancer\u2014Five MicroRNAs in a Prognostic Index","volume":"36","author":"Schultz","year":"2012","journal-title":"World J. Surg."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"73345","DOI":"10.18632\/oncotarget.20277","article-title":"Prognostic Value of MicroRNA Expression Levels in Pancreatic Adenocarcinoma: A Review of the Literature","volume":"8","author":"Wald","year":"2017","journal-title":"Oncotarget"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s12943-015-0400-7","article-title":"Exosome-Mediated MicroRNA Signaling from Breast Cancer Cells Is Altered by the Anti-Angiogenesis Agent Docosahexaenoic Acid (DHA)","volume":"14","author":"Hannafon","year":"2015","journal-title":"Mol. Cancer"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/jhbp.601","article-title":"Exosome-Encapsulated MicroRNA-4525, MicroRNA-451a and MicroRNA-21 in Portal Vein Blood Is a High-Sensitive Liquid Biomarker for the Selection of High-Risk Pancreatic Ductal Adenocarcinoma Patients","volume":"26","author":"Kawamura","year":"2019","journal-title":"J. Hepato-Biliary-Pancreat. Sci."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"7509","DOI":"10.12659\/MSM.917038","article-title":"MiRNA-339-5p Plays an Important Role in Invasion and Migration of Pancreatic Cancer Cells","volume":"25","author":"Yu","year":"2019","journal-title":"Med. Sci. Monit."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1002\/ijc.29324","article-title":"Combined Evaluation of a Panel of Protein and MiRNA Serum-Exosome Biomarkers for Pancreatic Cancer Diagnosis Increases Sensitivity and Specificity","volume":"136","author":"Madhavan","year":"2015","journal-title":"Int. J. Cancer"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.canlet.2017.02.019","article-title":"A MicroRNA Signature in Circulating Exosomes Is Superior to Exosomal Glypican-1 Levels for Diagnosing Pancreatic Cancer","volume":"393","author":"Lai","year":"2017","journal-title":"Cancer Lett."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1245\/s10434-019-07269-z","article-title":"Pancreatic Juice Exosomal MicroRNAs as Biomarkers for Detection of Pancreatic Ductal Adenocarcinoma","volume":"26","author":"Nakamura","year":"2019","journal-title":"Ann. Surg. Oncol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"539","DOI":"10.3892\/ijo.2014.2743","article-title":"Circulating MiR-483-3p and MiR-21 Is Highly Expressed in Plasma of Pancreatic Cancer","volume":"46","author":"Abue","year":"2015","journal-title":"Int. J. Oncol."},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Mortoglou, M., Miralles, F., Arisan, E.D., Dart, A., Jurcevic, S., Lange, S., and Uysal-Onganer, P. (2022). MicroRNA-21 Regulates Stemness in Pancreatic Ductal Adenocarcinoma Cells. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23031275"},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Girolimetti, G., Pelisenco, I.A., Eusebi, L.H., Ricci, C., Cavina, B., Kurelac, I., Verri, T., Calcagnile, M., Alifano, P., and Salvi, A. (2024). Dysregulation of a Subset of Circulating and Vesicle-Associated MiRNA in Pancreatic Cancer. Non-Coding RNA, 10.","DOI":"10.3390\/ncrna10030029"},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Xu, X., Bhandari, K., Xu, C., Morris, K., and Ding, W.-Q. (2023). MiR-18a and MiR-106a Signatures in Plasma Small EVs Are Promising Biomarkers for Early Detection of Pancreatic Ductal Adenocarcinoma. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24087215"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1245\/s10434-011-1602-x","article-title":"MicroRNA Expression as a Predictive Marker for Gemcitabine Response after Surgical Resection of Pancreatic Cancer","volume":"18","author":"Ohuchida","year":"2011","journal-title":"Ann. Surg. Oncol."},{"key":"ref_79","first-page":"201","article-title":"Differential Signature of Fecal MicroRNAs in Patients with Pancreatic Cancer","volume":"6","author":"Ren","year":"2012","journal-title":"Mol. Med. Rep."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"14153","DOI":"10.18632\/oncotarget.3686","article-title":"MiR-221\/222 Induces Pancreatic Cancer Progression through the Regulation of Matrix Metalloproteinases","volume":"6","author":"Xu","year":"2015","journal-title":"Oncotarget"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"21046","DOI":"10.18632\/oncotarget.4124","article-title":"MicroRNA-301a-3p Promotes Pancreatic Cancer Progression via Negative Regulation of SMAD4","volume":"6","author":"Xia","year":"2015","journal-title":"Oncotarget"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1038\/ctg.2013.18","article-title":"Investigating MicroRNA Expression Profiles in Pancreatic Cystic Neoplasms","volume":"5","author":"Lee","year":"2014","journal-title":"Clin. Transl. Gastroenterol."},{"key":"ref_83","first-page":"4638","article-title":"Evaluation of MiR-429 as a Novel Serum Biomarker for Pancreatic Ductal Adenocarcinoma and Analysis Its Tumor Suppressor Function and Target Genes","volume":"26","author":"Huang","year":"2022","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1586\/14737159.2015.1112273","article-title":"Circulating MicroRNAs as Diagnostic Biomarkers for Pancreatic Cancer","volume":"15","author":"Meijer","year":"2015","journal-title":"Expert Rev. Mol. Diagn."},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Amrutkar, M., and Gladhaug, I.P. (2017). Pancreatic Cancer Chemoresistance to Gemcitabine. Cancers, 9.","DOI":"10.3390\/cancers9110157"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"179","DOI":"10.2147\/TCRM.S154226","article-title":"The Role of MiRNAs in the Diagnosis, Chemoresistance, and Prognosis of Pancreatic Ductal Adenocarcinoma","volume":"14","author":"Ren","year":"2018","journal-title":"Ther. Clin. Risk Manag."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/bjc.2017.18","article-title":"Exosomes Confer Chemoresistance to Pancreatic Cancer Cells by Promoting ROS Detoxification and MiR-155-Mediated Suppression of Key Gemcitabine-Metabolising Enzyme, DCK","volume":"116","author":"Patel","year":"2017","journal-title":"Br. J. Cancer"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s13402-019-00476-6","article-title":"Exosomes Derived from Cancer Stem Cells of Gemcitabine-Resistant Pancreatic Cancer Cells Enhance Drug Resistance by Delivering MiR-210","volume":"43","author":"Yang","year":"2020","journal-title":"Cell Oncol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"5287","DOI":"10.1158\/0008-5472.CAN-18-0124","article-title":"Transfer of MiRNA in Macrophage-Derived Exosomes Induces Drug Resistance in Pancreatic Adenocarcinoma","volume":"78","author":"Binenbaum","year":"2018","journal-title":"Cancer Res."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.18632\/oncotarget.2714","article-title":"Down-Regulation of MiR-223 Reverses Epithelial-Mesenchymal Transition in Gemcitabine-Resistant Pancreatic Cancer Cells","volume":"6","author":"Ma","year":"2015","journal-title":"Oncotarget"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.3892\/ijo.2015.3076","article-title":"MiR-15b Promotes Epithelial-Mesenchymal Transition by Inhibiting SMURF2 in Pancreatic Cancer","volume":"47","author":"Zhang","year":"2015","journal-title":"Int. J. Oncol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1159\/000503225","article-title":"MicroRNA-296-5p Promotes Cell Invasion and Drug Resistance by Targeting Bcl2-Related Ovarian Killer, Leading to a Poor Prognosis in Pancreatic Cancer","volume":"101","author":"Okazaki","year":"2019","journal-title":"Digestion"},{"key":"ref_93","first-page":"1886","article-title":"Downregulation of MiR-301a-3p Sensitizes Pancreatic Cancer Cells to Gemcitabine Treatment via PTEN","volume":"9","author":"Xia","year":"2017","journal-title":"Am. J. Transl. Res."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"111543","DOI":"10.1016\/j.yexcr.2019.111543","article-title":"Exosomal MiRNA-106b from Cancer-Associated Fibroblast Promotes Gemcitabine Resistance in Pancreatic Cancer","volume":"383","author":"Fang","year":"2019","journal-title":"Exp. Cell Res."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.bbrc.2019.01.030","article-title":"Leptin-Elicited MiRNA-342-3p Potentiates Gemcitabine Resistance in Pancreatic Ductal Adenocarcinoma","volume":"509","author":"Ma","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/s41419-017-0233-y","article-title":"The MiR-135b\u2013BMAL1\u2013YY1 Loop Disturbs Pancreatic Clockwork to Promote Tumourigenesis and Chemoresistance","volume":"9","author":"Jiang","year":"2018","journal-title":"Cell Death Dis."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/bjc.2013.320","article-title":"MiR-320c Regulates Gemcitabine-Resistance in Pancreatic Cancer via SMARCC1","volume":"109","author":"Iwagami","year":"2013","journal-title":"Br. J. Cancer"},{"key":"ref_98","doi-asserted-by":"crossref","unstructured":"Ghosh, S. (2019). Cisplatin: The First Metal Based Anticancer Drug. Bioorg. Chem., 88.","DOI":"10.1016\/j.bioorg.2019.102925"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"148","DOI":"10.2478\/raon-2019-0018","article-title":"Cisplatin and beyond: Molecular mechanisms of action and drug resistance development in cancer chemotherapy","volume":"53","author":"Makovec","year":"2019","journal-title":"Radiol. Oncol."},{"key":"ref_100","first-page":"2798","article-title":"The Effects of MiRNA-1180 on Suppression of Pancreatic Cancer","volume":"9","author":"Gu","year":"2017","journal-title":"Am. J. Transl. Res."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/cgt.2016.23","article-title":"Evidence for the Role of MicroRNA 374b in Acquired Cisplatin Resistance in Pancreatic Cancer Cells","volume":"23","author":"Schreiber","year":"2016","journal-title":"Cancer Gene Ther."},{"key":"ref_102","doi-asserted-by":"crossref","unstructured":"Ji, Q., Hao, X., Zhang, M., Tang, W., Yang, M., Li, L., Xiang, D., DeSano, J.T., Bommer, G.T., and Fan, D. (2009). MicroRNA MiR-34 Inhibits Human Pancreatic Cancer Tumor-Initiating Cells. PLoS ONE, 4.","DOI":"10.1371\/journal.pone.0006816"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.cbi.2019.01.032","article-title":"Oxidized Phospholipids in Doxorubicin-Induced Cardiotoxicity","volume":"303","author":"Koleini","year":"2019","journal-title":"Chem. Biol. Interact."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"119527","DOI":"10.1016\/j.lfs.2021.119527","article-title":"A Comprehensive Review on Time-Tested Anticancer Drug Doxorubicin","volume":"278","author":"Sritharan","year":"2021","journal-title":"Life Sci."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/s41419-019-2053-8","article-title":"MiR-223 Overexpression Inhibits Doxorubicin-Induced Autophagy by Targeting FOXO3a and Reverses Chemoresistance in Hepatocellular Carcinoma Cells","volume":"10","author":"Zhou","year":"2019","journal-title":"Cell Death Dis."},{"key":"ref_106","first-page":"7696","article-title":"Increased MiR-142 and Decreased DJ-1 Enhance the Sensitivity of Pancreatic Cancer Cell to Adriamycin","volume":"22","author":"Han","year":"2018","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_107","doi-asserted-by":"crossref","unstructured":"Sethy, C., and Kundu, C.N. (2021). 5-Fluorouracil (5-FU) Resistance and the New Strategy to Enhance the Sensitivity against Cancer: Implication of DNA Repair Inhibition. Biomed. Pharmacother., 137.","DOI":"10.1016\/j.biopha.2021.111285"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"5820","DOI":"10.1158\/0008-5472.CAN-08-2819","article-title":"Epithelial to Mesenchymal Transition Contributes to Drug Resistance in Pancreatic Cancer","volume":"69","author":"Arumugam","year":"2009","journal-title":"Cancer Res."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.canlet.2017.02.020","article-title":"The Underlying Mechanisms of Non-Coding RNAs in the Chemoresistance of Pancreatic Cancer","volume":"397","author":"Xiong","year":"2017","journal-title":"Cancer Lett."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"3967","DOI":"10.7150\/thno.40566","article-title":"A MiR-146a-5p\/TRAF6\/NF-KB P65 Axis Regulates Pancreatic Cancer Chemoresistance: Functional Validation and Clinical Significance","volume":"10","author":"Meng","year":"2020","journal-title":"Theranostics"},{"key":"ref_111","first-page":"473","article-title":"Gemcitabine Enhances OSI-027 Cytotoxicity by Upregulation of MiR-663a in Pancreatic Ductal Adenocarcinoma Cells","volume":"11","author":"Huang","year":"2019","journal-title":"Am. J. Transl. Res."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1080\/15384101.2015.1006048","article-title":"ZEB1: At the Crossroads of Epithelial-Mesenchymal Transition, Metastasis and Therapy Resistance","volume":"14","author":"Zhang","year":"2015","journal-title":"Cell Cycle"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.3892\/ijo.2017.4099","article-title":"Novel Crosstalk between KLF4 and ZEB1 Regulates Gemcitabine Resistance in Pancreatic Ductal Adenocarcinoma","volume":"51","author":"Wang","year":"2017","journal-title":"Int. J. Oncol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"e3129","DOI":"10.1038\/cddis.2017.530","article-title":"MiR-3656 Expression Enhances the Chemosensitivity of Pancreatic Cancer to Gemcitabine through Modulation of the RHOF\/EMT Axis","volume":"8","author":"Yang","year":"2017","journal-title":"Cell Death Dis."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"6704","DOI":"10.1158\/0008-5472.CAN-09-1298","article-title":"Up-Regulation of MiR-200 and Let-7 by Natural Agents Leads to the Reversal of Epithelial-to-Mesenchymal Transition in Gemcitabine-Resistant Pancreatic Cancer Cells","volume":"69","author":"Li","year":"2009","journal-title":"Cancer Res."},{"key":"ref_116","first-page":"1697","article-title":"Downregulation of MiR-183 Inhibits the Growth of PANC-1 Pancreatic Cancer Cells in Vitro and in Vivo, and Increases Chemosensitivity to 5-fluorouracil and Gemcitabine","volume":"17","author":"Yang","year":"2019","journal-title":"Exp. Ther. Med."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.3892\/or.2013.2297","article-title":"MiRNA-181b Increases the Sensitivity of Pancreatic Ductal Adenocarcinoma Cells to Gemcitabine in Vitro and in Nude Mice by Targeting BCL-2","volume":"29","author":"Cai","year":"2013","journal-title":"Oncol. Rep."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"44466","DOI":"10.18632\/oncotarget.6298","article-title":"Upregulation of MiR-181c Contributes to Chemoresistance in Pancreatic Cancer by Inactivating the Hippo Signaling Pathway","volume":"6","author":"Chen","year":"2015","journal-title":"Oncotarget"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.canlet.2018.10.038","article-title":"Bioengineered MiRNA-1291 Prodrug Therapy in Pancreatic Cancer Cells and Patient-Derived Xenograft Mouse Models","volume":"442","author":"Tu","year":"2019","journal-title":"Cancer Lett."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.3892\/ol.2016.4101","article-title":"Circulating MicroRNA Profile Predicts Disease Progression in Patients Receiving Second-Line Treatment of Lapatinib and Capecitabine for Metastatic Pancreatic Cancer","volume":"11","author":"Tian","year":"2016","journal-title":"Oncol. Lett."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1007\/s12094-012-0999-4","article-title":"Resveratrol Induces Apoptosis of Pancreatic Cancers Cells by Inhibiting MiR-21 Regulation of BCL-2 Expression","volume":"15","author":"Liu","year":"2013","journal-title":"Clin. Transl. Oncol."},{"key":"ref_122","doi-asserted-by":"crossref","unstructured":"Petrelli, F., Parisi, A., Tomasello, G., Mini, E., Arru, M., Russo, A., Garrone, O., Khakoo, S., Ardito, R., and Ghidini, M. (2023). Comparison of Different Second Line Treatments for Metastatic Pancreatic Cancer: A Systematic Review and Network Meta-Analysis. BMC Gastroenterol., 23.","DOI":"10.1186\/s12876-023-02853-w"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"6987","DOI":"10.3748\/wjg.v22.i31.6987","article-title":"FOLFIRINOX and Translational Studies: Towards Personalized Therapy in Pancreatic Cancer","volume":"22","author":"Caparello","year":"2016","journal-title":"World J. Gastroenterol."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"688","DOI":"10.20892\/j.issn.2095-3941.2019.0252","article-title":"The Challenge of Drug Resistance in Pancreatic Ductal Adenocarcinoma: A Current Overview","volume":"16","author":"Mesas","year":"2019","journal-title":"Cancer Biol. Med."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"2819","DOI":"10.3389\/fimmu.2019.02819","article-title":"Natural Killer Cell-Derived Exosomal MiR-3607-3p Inhibits Pancreatic Cancer Progression by Targeting IL-26","volume":"10","author":"Sun","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.gene.2017.02.025","article-title":"Kr\u00fcppel-like Factor 4 (KLF4): What We Currently Know","volume":"611","author":"Ghaleb","year":"2017","journal-title":"Gene"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"326","DOI":"10.7150\/ijbs.15017","article-title":"MicroRNA Targeted Therapeutic Approach for Pancreatic Cancer","volume":"12","author":"Li","year":"2016","journal-title":"Int. J. Biol. Sci."},{"key":"ref_128","first-page":"9154","article-title":"MiR-451, a Potential Prognostic Biomarker and Tumor Suppressor for Gastric Cancer","volume":"8","author":"Su","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s40880-016-0128-9","article-title":"MicroRNA-506 Is up-Regulated in the Development of Pancreatic Ductal Adenocarcinoma and Is Associated with Attenuated Disease Progression","volume":"35","author":"Cheng","year":"2016","journal-title":"Chin. J. Cancer"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1242\/bio.021774","article-title":"MiR-142 Modulates Human Pancreatic Cancer Proliferation and Invasion by Targeting Hypoxia-Inducible Factor 1 (HIF-1\u03b1) in the Tumor Microenvironments","volume":"6","author":"Lu","year":"2017","journal-title":"Biol. Open"},{"key":"ref_131","doi-asserted-by":"crossref","unstructured":"Fathi, M., Ghafouri-Fard, S., Abak, A., and Taheri, M. (2021). Emerging Roles of MiRNAs in the Development of Pancreatic Cancer. Biomed. Pharmacother., 141.","DOI":"10.1016\/j.biopha.2021.111914"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1038\/onc.2012.598","article-title":"Methylation-Mediated Silencing of the MiR-124 Genes Facilitates Pancreatic Cancer Progression and Metastasis by Targeting Rac1","volume":"33","author":"Wang","year":"2014","journal-title":"Oncogene"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/nature22341","article-title":"Exosomes Facilitate Therapeutic Targeting of Oncogenic KRAS in Pancreatic Cancer","volume":"546","author":"Kamerkar","year":"2017","journal-title":"Nature"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.omtn.2018.08.012","article-title":"MiR-7 Suppresses Tumor Progression by Directly Targeting MAP3K9 in Pancreatic Cancer","volume":"13","author":"Xia","year":"2018","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"ref_135","doi-asserted-by":"crossref","unstructured":"Sureban, S.M., May, R., Qu, D., Weygant, N., Chandrakesan, P., Ali, N., Lightfoot, S.A., Pantazis, P., Rao, C.V., and Postier, R.G. (2013). DCLK1 Regulates Pluripotency and Angiogenic Factors via MicroRNA-Dependent Mechanisms in Pancreatic Cancer. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0073940"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cbi.2019.02.026","article-title":"Overexpression of MicroRNA-519d-3p Suppressed the Growth of Pancreatic Cancer Cells by Inhibiting Ribosomal Protein S15A-Mediated Wnt\/\u03b2-Catenin Signaling","volume":"304","author":"Liang","year":"2019","journal-title":"Chem. Biol. Interact."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"27066","DOI":"10.3402\/jev.v4.27066","article-title":"Biological Properties of Extracellular Vesicles and Their Physiological Functions","volume":"4","author":"Siljander","year":"2015","journal-title":"J. Extracell. Vesicles"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1021\/acs.accounts.9b00109","article-title":"Drug Delivery with Extracellular Vesicles: From Imagination to Innovation","volume":"52","author":"Kooijmans","year":"2019","journal-title":"Acc. Chem. Res."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.apsb.2016.02.001","article-title":"Exosomes as Therapeutic Drug Carriers and Delivery Vehicles across Biological Membranes: Current Perspectives and Future Challenges","volume":"6","author":"Ha","year":"2016","journal-title":"Acta Pharm. Sin. B"},{"key":"ref_140","doi-asserted-by":"crossref","unstructured":"Butreddy, A., Kommineni, N., and Dudhipala, N. (2021). Exosomes as Naturally Occurring Vehicles for Delivery of Biopharmaceuticals: Insights from Drug Delivery to Clinical Perspectives. Nanomaterials, 11.","DOI":"10.3390\/nano11061481"},{"key":"ref_141","doi-asserted-by":"crossref","unstructured":"Munir, J., Yoon, J.K., and Ryu, S. (2020). Therapeutic MiRNA-Enriched Extracellular Vesicles: Current Approaches and Future Prospects. Cells, 9.","DOI":"10.3390\/cells9102271"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"113801","DOI":"10.1016\/j.addr.2021.05.011","article-title":"Extracellular Vesicles as a Drug Delivery System: A Systematic Review of Preclinical Studies","volume":"175","author":"Tong","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1016\/j.apsb.2019.11.013","article-title":"Bone Marrow Mesenchymal Stem Cells-Derived Exosomes for Penetrating and Targeted Chemotherapy of Pancreatic Cancer","volume":"10","author":"Zhou","year":"2020","journal-title":"Acta Pharm. Sin. B"}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/16\/12\/2179\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:56:00Z","timestamp":1760108160000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/16\/12\/2179"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,8]]},"references-count":143,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2024,6]]}},"alternative-id":["cancers16122179"],"URL":"https:\/\/doi.org\/10.3390\/cancers16122179","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,8]]}}}